122 related articles for article (PubMed ID: 16972299)
1. Proteomic analysis of cancer tissues: shedding light on carcinogenesis and possible biomarkers.
Kuramitsu Y; Nakamura K
Proteomics; 2006 Oct; 6(20):5650-61. PubMed ID: 16972299
[TBL] [Abstract][Full Text] [Related]
2. Increased expression and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus.
Kuramitsu Y; Harada T; Takashima M; Yokoyama Y; Hidaka I; Iizuka N; Toda T; Fujimoto M; Zhang X; Sakaida I; Okita K; Oka M; Nakamura K
Electrophoresis; 2006 Apr; 27(8):1651-8. PubMed ID: 16609938
[TBL] [Abstract][Full Text] [Related]
3. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
[TBL] [Abstract][Full Text] [Related]
4. Proteomics for the early detection and treatment of hepatocellular carcinoma.
Feng JT; Shang S; Beretta L
Oncogene; 2006 Jun; 25(27):3810-7. PubMed ID: 16799622
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
[TBL] [Abstract][Full Text] [Related]
6. Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma.
Lee NP; Leung KW; Cheung N; Lam BY; Xu MZ; Sham PC; Lau GK; Poon RT; Fan ST; Luk JM
Proteomics; 2008 May; 8(10):2136-49. PubMed ID: 18425728
[TBL] [Abstract][Full Text] [Related]
7. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
El-Aneed A; Banoub J
Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
[TBL] [Abstract][Full Text] [Related]
8. Proteomics in pancreatic cancer research.
Cecconi D; Palmieri M; Donadelli M
Proteomics; 2011 Feb; 11(4):816-28. PubMed ID: 21229586
[TBL] [Abstract][Full Text] [Related]
9. Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.
Kischel P; Waltregny D; Castronovo V
Expert Rev Proteomics; 2007 Dec; 4(6):727-39. PubMed ID: 18067412
[TBL] [Abstract][Full Text] [Related]
10. High-dimensional biology to comprehend hepatocellular carcinoma.
Vivekanandan P; Singh OV
Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model.
Tong A; Wu L; Lin Q; Lau QC; Zhao X; Li J; Chen P; Chen L; Tang H; Huang C; Wei YQ
Proteomics; 2008 May; 8(10):2012-23. PubMed ID: 18491315
[TBL] [Abstract][Full Text] [Related]
13. KL-6 mucin in metastatic liver cancer tissues from primary colorectal carcinoma.
Zhang K; Tang W; Qu X; Guo Q; Inagaki Y; Seyama Y; Abe H; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
Hepatogastroenterology; 2009; 56(93):960-3. PubMed ID: 19760920
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tsunoda T; Nakatsuru S; Nakagawa H; Nakamura Y; Baba H; Nishimura Y
Clin Cancer Res; 2008 Oct; 14(20):6487-95. PubMed ID: 18927288
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of colorectal cancer: discovering novel biomarkers.
Skandarajah AR; Moritz RL; Tjandra JJ; Simpson RJ
Expert Rev Proteomics; 2005 Oct; 2(5):681-92. PubMed ID: 16209648
[TBL] [Abstract][Full Text] [Related]
18. Proteomic approaches in lung cancer biomarker development.
Cho JY; Sung HJ
Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
[TBL] [Abstract][Full Text] [Related]
19. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
20. Artificial neural networks and decision tree model analysis of liver cancer proteomes.
Luk JM; Lam BY; Lee NP; Ho DW; Sham PC; Chen L; Peng J; Leng X; Day PJ; Fan ST
Biochem Biophys Res Commun; 2007 Sep; 361(1):68-73. PubMed ID: 17644064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
